Free Trial

Isthmus Partners LLC Sells 16,490 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Healthpeak Properties logo with Finance background
Remove Ads

Isthmus Partners LLC decreased its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 3.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 489,529 shares of the real estate investment trust's stock after selling 16,490 shares during the quarter. Isthmus Partners LLC owned 0.07% of Healthpeak Properties worth $9,923,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. AdvisorNet Financial Inc boosted its position in shares of Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock valued at $44,000 after purchasing an additional 563 shares during the period. Exchange Traded Concepts LLC boosted its position in shares of Healthpeak Properties by 10.0% in the 4th quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust's stock valued at $133,000 after purchasing an additional 598 shares during the period. Commerzbank Aktiengesellschaft FI boosted its position in shares of Healthpeak Properties by 3.9% in the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 21,002 shares of the real estate investment trust's stock valued at $420,000 after purchasing an additional 797 shares during the period. Mirador Capital Partners LP boosted its position in Healthpeak Properties by 2.8% during the 4th quarter. Mirador Capital Partners LP now owns 33,132 shares of the real estate investment trust's stock worth $672,000 after acquiring an additional 901 shares during the period. Finally, Concurrent Investment Advisors LLC boosted its position in Healthpeak Properties by 10.1% during the 4th quarter. Concurrent Investment Advisors LLC now owns 10,117 shares of the real estate investment trust's stock worth $205,000 after acquiring an additional 927 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.

Remove Ads

Healthpeak Properties Stock Performance

Shares of DOC stock traded down $0.12 during trading on Wednesday, reaching $20.21. The company had a trading volume of 3,754,869 shares, compared to its average volume of 4,730,672. The firm's 50 day simple moving average is $20.21 and its two-hundred day simple moving average is $21.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a one year low of $16.66 and a one year high of $23.26. The company has a market capitalization of $14.13 billion, a PE ratio of 57.73, a PEG ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.04%. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.

Analyst Ratings Changes

A number of equities research analysts have commented on DOC shares. Wedbush decreased their price objective on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, February 14th. Scotiabank decreased their price objective on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research report on Friday, February 28th. Mizuho decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Thursday, December 5th. Wells Fargo & Company decreased their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. Finally, Robert W. Baird decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $23.92.

Get Our Latest Stock Report on DOC

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Stories

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

AMD’s stock has dropped over 50% in the last 12 months, but is the worst over? Find out if AMD is set for a rebound—or if it’s still a falling knife.

Related Videos

Is Micron on Par with AMD? BUY Now or DEAD Money?
AMD Stock’s Big Drop: Buy the Dip or More Pain Ahead?
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads